Peripheral neuropathy decisions — 2025

The Board denied the veteran's claims for increased ratings and service connection, as well as a TDIU.

The Board granted service connection for alcohol dependence and peripheral neuropathy of the lower extremities, both secondary to service-connected conditions.

The Board granted service connection for hyperthyroidism as secondary to in-service exposure to herbicide agents, and for neuropathy of the right and left lower extremities and right eye exophthalmos and diplopia as secondary to service-connected hypothyroidism.

The Board granted readjudication of the claims for service connection for headaches, a sleep condition (OSA), Parkinsonism (including Parkinson's disease), unspecified depressive disorder, CAD with atrial fibrillation, bilateral upper extremity neuropathy, and bilateral lower extremity neuropathy based on new evidence. The claim for hyperhidrosis was denied as no new relevant evidence was received.

The Board denied the veteran's claims for increased ratings and other benefits due to insufficient evidence of disability severity beyond the current ratings.

The Board denied earlier effective dates for service connection and ratings related to chronic renal failure, peripheral neuropathy of the left lower extremity, and special monthly compensation.

The Board remands the claims for service connection for a back condition, left and right upper extremity neuropathy, left and right lower extremity neuropathy, and erectile dysfunction to afford the Veteran VA examinations and obtain medical opinions.

The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance from July 28, 2023, through September 21, 2024.

The Board denied service connection for a kidney disability, as there was no evidence of a current disability. The claims for cervical radiculopathy, left hip strain, and right hip strain were remanded due to inadequate medical opinions.

The Board remands the claims for service connection for various conditions, including foot, knee, hip, shoulder, and peripheral neuropathy conditions, to ensure proper development of evidence.

The appeal seeking a disability rating in excess of 40 percent for left upper extremity neuropathy with nerve compression was dismissed due to the Veteran not withdrawing his prior Supplemental Claim Application.

The Board denied service connection for various disabilities, including sinusitis, lung disability, liver disability, kidney disability, sleep apnea, shoulder disabilities, peripheral neuropathy of the extremities, and flatfoot, as there was no evidence to support a link between these conditions and the Veteran's active military service.

The Board denied the veteran's claims for increased ratings for right shoulder disability, residuals of fracture of the right foot, and neuropathy of the right foot.

The Board grants service connection for bilateral lower extremity peripheral neuropathy based on the Veteran's credible reports and a positive nexus opinion from the December 2024 VA examiner.

The Board denied an initial rating in excess of 10 percent for plantar fasciitis, right foot, and dismissed the issue of entitlement to an increased rating for service-connected inflammation of the anterior tibial nerve (right lower extremity neuropathy, peroneal and sural nerves).

The Board granted service connection for type two diabetes mellitus, diabetic nephropathy (claimed as kidney disease), erectile dysfunction, bilateral lower extremity diabetic peripheral neuropathy, and hypertension, all found to be secondary to the Veteran's service-connected left knee disability.

The Board remands the claims for service connection for hypertension and peripheral neuropathy of both upper and lower extremities due to insufficient medical evidence.

The Board denied ratings higher than 10 percent for deep vein thrombosis with post-thrombotic syndrome and bilateral lower extremity idiopathic peripheral neuropathy based on the evidence of record.

The Board remands the claims for service connection for peripheral neuropathy of both upper and lower extremities due to a need for further clarity on the nature and etiology of the Veteran's conditions.

The Board denied the veteran's claims for an increased rating for posttraumatic stress disorder, service connection for gallbladder disease and functional gastrointestinal disorders, and remanded claims for peripheral neuropathy, gastroesophageal reflux disease, and residuals of liver disease.